Balanced news tone
News Sentiment
DVA sentiment intelligence
DaVita HealthCare Partners Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
81/100 classification confidence.
directly relevant articles
high-authority source matches
-0.9% over one week, +11.6% over four weeks, trend active, and materially above fair value.
DaVita: I Believe This Is Overvalued (NYSE:DVA)
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
DaVita Inc. outlines growth path as kidney care demand rises
DaVita Inc., a major provider of dialysis services in the US, is positioned for growth as the demand for chronic kidney care increases due to an aging population. The company focuses on operational efficiency, long-term treatment programs, and diverse care models including home-b
- Tone
- Positive 72/100
- Event
- Macro sensitivity
- Published
- 07 Jul 2026 08:27
- Source
- AD HOC NEWS
DaVita (DVA) Stock Could Be 19% Overvalued Despite Strong Q1 Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Is DaVita Inc. (DVA) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
DaVita (DVA) Expands Integrated Kidney Care With AI Tools For Dialysis Care
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- Market source
Healthcare Stocks Investors Are Turning To After The Weak US Jobs Report
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 03 Jul 2026 07:00
- Source
- simplywall.st
Should Value Investors Buy DaVita (DVA) Stock?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Market source
Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 Jul 2026 07:00
- Source
- CNBC
DaVita Healthcare stock hits all-time high at 221.78 USD
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 07:00
- Source
- Investing.com
Why the Market Dipped But DaVita HealthCare (DVA) Gained Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 07:00
- Source
- Market source
Stronger Q1 Results And Kidney Care Expansion Might Change The Case For Investing In DaVita (DVA)
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 24 Jun 2026 07:00
- Source
- Market source
How Is DaVita's Stock Performance Compared to Other Healthcare Stocks
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Market source
Reflecting On Healthcare Equipment and Supplies Stocks’ Q1 Earnings: GE HealthCare (NASDAQ:GEHC)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Jun 2026 07:00
- Source
- StockStory
DaVita (DVA) Stock After 82% YTD Surge Is The Price Still Justified
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 14 Jun 2026 07:00
- Source
- Market source
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 07:00
- Source
- Investopedia
DaVita (DVA): Company Profile, Stock Price, News, Rankings
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- Fortune
SGRY - Surgery Partners Inc Stock Price and Quote
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 14:30
- Source
- Finviz
Is DaVita (DVA) Stock Undervalued Right Now?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Market source
A Look Back at Healthcare Providers & Services Stocks’ Q1 Earnings: McKesson (NYSE:MCK) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 May 2026 07:00
- Source
- Market source
Why is DaVita HealthCare Partners stock surging today?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 06 May 2026 07:00
- Source
- Investing.com
Earnings call transcript: DaVita surpasses Q1 2026 forecasts with strong EPS growth
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- Investing.com
This Market Pro Likes Healthcare Stocks, Dislikes Software. How He Picks Winners.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Apr 2026 07:00
- Source
- Barron's
GE HealthCare (NASDAQ:GEHC) Posts Better-Than-Expected Sales In Q1 CY2026 But Stock Drops
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Apr 2026 07:00
- Source
- StockStory
3 Healthcare Stocks That Fall Short
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- StockStory
A $560M healthcare property deal covers 35 sites across the U.S.
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 22 Apr 2026 07:00
- Source
- Stock Titan
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Surgery Partners posts Q1 results May 5, webcast at 8:30 ET
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Apr 2026 07:00
- Source
- Stock Titan
Nearly a third of Modern Healthcare's Top 100 hospitals are HCA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Apr 2026 07:00
- Source
- Stock Titan
A Look Back at Healthcare Providers & Services Stocks’ Q4 Earnings: The Ensign Group (NASDAQ:ENSG) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 Mar 2026 07:00
- Source
- Market source
DaVita reports progress in value-based kidney care programs
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Investing.com
Healthcare Stocks Are Trading at a Deep Discount. Eli Lilly and Others Are Worth a Look.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Mar 2026 07:00
- Source
- Barron's